Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hearing test program for cancer survivors shows promise

NCT ID NCT05789316

First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 21 times

Summary

This study tested a hearing screening program for head and neck cancer survivors who received cisplatin chemotherapy. 55 adults who had completed treatment were invited to get their hearing checked. The goal was to see if the program was practical and helpful for catching hearing loss early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER SURVIVORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.